dr krishna ella

FE Healthcare Summit: Covaxin is outcome of complex science to achieve best efficacy, says Dr. Krishna Ella

by
FE Healthcare Summit: Covaxin is outcome of complex science to achieve best efficacy, says Dr. Krishna Ella

Bharat Biotech has submitted its safety data to the Drugs Controller General of India (DCGI) based on the phase 2/3 clinical trials for manufacturing vaccine for children aged between 2 and 18. Bharat Biotech inactivated vaccine Covaxin is the outcome of complex scientific process that is needed to achieve best efficacy and  immunogenicity, said Dr. … Read more

Bharat Biotech to provide efficacy data of Covaxin in two weeks; said MD Dr Krishna Ella

by
Bharat Biotech to provide efficacy data of Covaxin in two weeks; said MD Dr Krishna Ella

Covaxin received emergency use approval from the Drug. Controller General of India on January 3. Efficacy data of Bharat Biotech’s Covid-19 vaccine, Covaxin that is being administered to front-line workers currently will be available in the next two weeks. According to the chairman of the Hyderabad-based vaccine maker, Dr Krishna Ella, this will be the … Read more